FDA Decision Signals New Competition For Some Of The Costliest Drugs

Share this content:
FDA Decision Signals New Competition For Some Of The Costliest Drugs
FDA Decision Signals New Competition For Some Of The Costliest Drugs
The FDA approved Zarxio on Friday, and it's the first time the agency has approved a so-called biosimilar, or close copy of an existing biotech medicine.
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




is free, fast, and customized just for you!




Already a member?

Sign In Now »